Financial professional

You manage client investments

Individual investor

You’re keeping track of personal investments

Institutional investor

You invest on behalf of institutions

We're here to help. Log in to connect with your sales consultant team.

Log inCreate an account
Sign up to have the latest insights delivered straight to your inbox.

Key takeaways from equity earnings calls

April 22, 2025 | Nicolas Janvier, CFA, Lead Portfolio Manager, Head of U.S. Equity Research

Policy uncertainty takes center stage.

Recent equity earnings calls provide valuable insights into the current state of various sectors and the broader economic landscape. Early indications are that a prevailing sense of caution dominates the outlook for 2025, as the most prominent theme across sectors is the widespread concern about tariffs and trade policy impacts. While some industries remain resilient, concerns over policy uncertainty, the future path of interest rates and trade relations have led to cautious sentiment among companies, with many adopting a wait-and-see approach.

 

Sector-specific trends

  • Financial services: Banks reported solid earnings, supported by favorable regulations and robust trading activity. However, forward-looking momentum remains mixed. The regulatory outlook under the Trump administration remains positive for banks, with potential increases in bank mergers and acquisitions activity expected. Scale is becoming increasingly important, as larger banks are better positioned to navigate the evolving regulatory landscape and capitalize on growth opportunities.
  • Insurance: The insurance sector remains a mix of stability and evolving risks. Property and casualty insurers continue to see strong margins, though elevated catastrophe losses persist as a challenge. The personal auto segment has become increasingly competitive following price hikes, while life insurance companies maintain steady underwriting trends. Overall, insurers are benefiting from higher interest rates, strengthening investment returns and capital reserves.
  • Retail and consumer: The retail and consumer sectors are facing an uncertain outlook after a strong holiday quarter. Margin pressures are mounting due to tariffs and inventory management challenges, prompting many retailers to offer conservative guidance for 2025. Companies remain uncertain whether these pressures are temporary or indicative of a longer term slowdown.
  • Technology and telecommunications: Enterprise IT is showing solid demand, although the outlook remains cautious. Federal budget constraints and macroeconomic headwinds have led to more measured guidance. Meanwhile, the telecommunications sector is experiencing significant pricing adjustments, with wireless carriers raising rates and broadband competition intensifying. Traditional linear TV continues to struggle with cord-cutting, while artificial intelligence infrastructure spending has emerged as a focal point for technology companies.
  • Medical devices: The medical devices sector remains one of the bright spots, with above-historical growth rates projected. Pricing pressures have eased, and the underlying market continues to expand. However, exposure to China presents uncertainties, as domestic brand favoritism and shifting trade policies create potential headwinds. Additionally, hospital capital expenditure constraints are being closely monitored, given their impact on long-term demand.

 

Companies exercising caution for the remainder of 2025

Tariff-related uncertainties are casting a shadow across multiple sectors. Companies are exploring mitigation strategies, including cost-cutting measures and supply chain diversification. Some industries are hopeful for exemptions, but overall, businesses are wary of increased costs and potential disruptions.

 

Exposure to China is another common challenge. China’s economic and policy landscape remains a source of concern for multinational corporations. For example, medical device companies are seeing increased competition from domestic brands, while trade policy uncertainties are affecting decision-making in several sectors. Broader policy changes in China continue to have ripple effects across industries ranging from health care to manufacturing.

 

Finally, weakening consumer sentiment has been noted, with year-to-date consumer spending hampered by weather and investor outlook. There is uncertainty about whether current pressures are transitory, adding to the skepticism.

 

Where are the opportunities?

There are pockets of optimism in this environment. In financial services, despite the cautious sentiment, banks are expected to deliver positive operating leverage in 2025. The favorable regulatory environment under the Trump administration and strong investment banking and trading activity contribute to a more optimistic outlook for the sector.

 

The medical devices sector is projecting above-historical growth, with a 4% growth rate compared with the traditional 3%. The pricing environment has improved from historical deflationary pressure, and solid underlying market growth supports a positive outlook. Finally, the outlook for the insurance sector is favorable, buoyed by solid underwriting trends and capital levels.

 

The bottom line

The notes from the recent earnings season calls suggest that companies are more guarded about 2025. Concerns about macro uncertainty and policy changes outweigh the areas of strength, particularly in consumer-facing and trade-sensitive sectors. While pockets of optimism exist, the overall sentiment remains cautious, as companies navigate the complexities of the current economic landscape. Companies are closely monitoring trade developments, consumer behavior and regulatory shifts as they prepare for the months ahead. Ultimately, adaptability and strategic planning will be key as businesses navigate an increasingly complex economic environment.

 

To find out more,
visit columbiathreadneedle.com

Columbia Management Investment Advisers, LLC is an investment adviser registered with the U.S. Securities and Exchange Commission.

Columbia Threadneedle Investments (Columbia Threadneedle) is the global brand name of the Columbia and Threadneedle group of companies.

The views expressed are as of the date given, may change as market or other conditions change and may differ from views expressed by other Columbia Management Investment Advisers, LLC (CMIA) associates or affiliates. Actual investments or investment decisions made by CMIA and its affiliates, whether for its own account or on behalf of clients, may not necessarily reflect the views expressed. This information is not intended to provide investment advice and does not take into consideration individual investor circumstances. Investment decisions should always be made based on an investor’s specific financial needs, objectives, goals, time horizon and risk tolerance. Asset classes described may not be appropriate for all investors. Past performance does not guarantee future results, and no forecast should be considered a guarantee either. Since economic and market conditions change frequently, there can be no assurance that the trends described here will continue or that any forecasts are accurate.

@2025 Columbia Threadneedle. All rights reserved.

CTBP0D7 (04/25) CTNA7859352.1

Sign up to have the latest insights delivered straight to your inbox.

ABOUT THE THOUGHT LEADER

Nicolas Janvier
Lead Portfolio Manager, Head of U.S. Equity Research

Nicolas Janvier, CFA

Nicolas Janvier is Head of U.S. Equity Research at Columbia Threadneedle Investments and has been with the company or legacy organizations for 20 years working as a U.S. equities portfolio manager in both our U.S. and London offices.

Latest Insights

May 14, 2025

Track fixed-income opportunities with this monthly update.

May 13, 2025

Value stocks are making a comeback. We look into the drivers and what this could mean for portfolios.

May 6, 2025

Overnight, tariffs shifted our forecasts and currently weigh significantly on our outlook for inflation, consumer sentiment, jobs and broadly for the sector.

Contact Us